版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Objective: To observe the influence of the photoreceptor apoptosis in the course of retinal degeneration to 17 region of visual cortex and its mechanism with the RCS rats as the animal model, and to observe the therapeut
2、ic effects of Ginaton (EGb761) on retinal dystrophy, and to explore the possible protective mechanism of EGb761.Methods: Choose RCS rats and SD rats at postnatal 9,15,20,25,30,35,40,60 days respectively. Observe the chan
3、ge of neurons of 17 region of visual cortex with Nissl staining and the expression of FasL and bcl-2 are detected by immunohistochemistry.A total of 48 male RCS rats were divided into control and EGb761 groups randomly.E
4、Gb761(100mg/kg/3d)was injected intraperitoneally in EGb761 group from postnatal 5 days. Similarly, saline was injected intraperitoneally in control group. The protective effects of EGb761 to retinal degeneration was asse
5、ssed by the method of HE and TUNEL staining. The expression of FasL and bcl-2 were detected by immunohistochemistry.Results: (1) Nissl staining: Compared with SD rats, section areas of neurons of 17 region of visual cor
6、tex of RCS rats were smaller, and there were obvious difference at postnatal 20,25,30,35 days groups. The decreasing tendency of cell number of 17 region of visual cortex of RCS rats is lower than SD rats and there are m
7、ore cells than SD rats. The difference has obvious significance at postnatal 30 and 35 days groups. (2) FasL and bcl-2 staining: Compared with SD rats, there are more FasL immunohistochemically positive cells in 1
8、7 region of visual cortex of RCS rats at postnatal 25,30,35,40 days groups and the optical density value(OD value) of the cells are higher at the four stage groups. There are more bcl-2 immunohistochemically positive cel
9、ls and the OD value of these cells are higher at postnatal 30,35,40 days groups. (3) HE staining: Compared with the control group, the inner nucleus layer(INL) of EGb761 group is thicker and the there are more cel
10、ls in ganglion cell layer(GCL)and INL and more photoreceptors at postnatal 20 and 25 days groups. There is no obvious difference between the EGb761 and the control group after postnatal 30 days. (4) FasL and bcl-2
11、 staining show that the EGb761 and control groups have similar expression pattern in FasL staining. From postnatal 15 to 25 days, there are less positive cells in the GCL and INL in EGb761 group than control group. Bcl-2
12、 staining show that EGb761 group and control group arc similar in expression pattern.TUNEL detectation show there are more positive cells in the outer nucleus layer(ONL)in EGb761 group than control group at postnatal 20
13、and 25 days groups. There is no obvious difference between EGb761 and control group at other stage groups.Conclusion: (1) EGb761 has therapeutic effect on the early stage of retinal degeneration. It might preserve more
14、photoreceptors. (2) EGb761 might preserve degenerated neurons in the early stage by inhibiting the expression of FasL, but its protective effect may have no relationship with the expression of bcl-2. (3) I
15、n the early stage of retinal degeneration of RCS rats there are more cells in 17 region of visual cortex than control group, and the section area of the cells are bigger. The expression of FasL in early stage might have
16、relationship with the differentiation and maturation of cells of visual cortex. The expression of FasL in visual cortex and in retina are in similar stages. It might be the adaptiveness of visual cortex to retinitis pigm
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫(kù)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 自體雪旺細(xì)胞鞏膜深層移植治療遺傳性視網(wǎng)膜變性的研究.pdf
- 常染色體隱性遺傳性視網(wǎng)膜變性患者的分子遺傳學(xué)研究.pdf
- 實(shí)驗(yàn)性視網(wǎng)膜色素變性的現(xiàn)代中藥治療.pdf
- 石斛散對(duì)視網(wǎng)膜色素變性治療作用的實(shí)驗(yàn)研究.pdf
- Wagner遺傳性玻璃體視網(wǎng)膜變性的臨床分析.pdf
- 兩個(gè)視網(wǎng)膜色素變性家系的分子遺傳學(xué)研究.pdf
- 視網(wǎng)膜色素變性大鼠的視網(wǎng)膜功能研究.pdf
- 針刺治療視網(wǎng)膜色素變性臨床觀察.pdf
- 視網(wǎng)膜色素變性患者視網(wǎng)膜色素變性1基因突變的檢測(cè)分析.pdf
- 淺談視網(wǎng)膜色素變性
- 常染色體顯性遺傳視網(wǎng)膜色素變性家系視網(wǎng)膜色素變性1基因(RP1)的突變分析.pdf
- 視網(wǎng)膜色素變性大家系的臨床研究和分子遺傳學(xué)研究.pdf
- 兩個(gè)遺傳性非綜合征型視網(wǎng)膜色素變性家系的基因突變檢測(cè)及定位.pdf
- RNA干擾治療視網(wǎng)膜色素變性的動(dòng)物實(shí)驗(yàn)研究.pdf
- 治視網(wǎng)膜色素變性秘方
- 視網(wǎng)膜色素變性治療的實(shí)驗(yàn)研究和循證評(píng)價(jià).pdf
- 視網(wǎng)膜色素變性大鼠視網(wǎng)膜多巴能無(wú)長(zhǎng)突細(xì)胞調(diào)節(jié)Melanopsin表達(dá)的機(jī)制研究.pdf
- 遺傳性視網(wǎng)膜病變模式動(dòng)物的的氧誘導(dǎo)視網(wǎng)膜病變觀察.pdf
- 一個(gè)中國(guó)視網(wǎng)膜色素變性家系的分子遺傳學(xué)分析
- 實(shí)驗(yàn)性視網(wǎng)膜色素上皮變性模型的建立及異體視網(wǎng)膜色素上皮細(xì)胞移植的初步研究.pdf
評(píng)論
0/150
提交評(píng)論